Variable | Whole subgroup | With CD8+ iTIL = 0 | With CD8+ iTIL ≥ 1 | |||
---|---|---|---|---|---|---|
 | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P |
HER2+/ER– |  | |||||
Age | 1.13 | 0.573 | 1.09 | 0.741 | 1.12 | 0.784 |
≥50 vs. <50 | (0.74 - 1.73) |  | (0.65 - 1.84) |  | (0.50 - 2.50) |  |
Grade | 2.23 | 0.007 | 2.05 | 0.039 | 2.55 | 0.134 |
3 vs. (1 and 2) | (1.24 - 4.01) | Â | (1.04 - 4.07) | Â | (0.75 - 8.65) | Â |
Tumor size | 1.67 | 0.026 | 1.43 | 0.198 | 2.53 | 0.025 |
>2 cm vs. ≤2 cm | (1.06 - 2.61) |  | (1.83 - 2.48) |  | (1.13 - 5.67) |  |
Nodal status | 1.95 | 0.008 | 1.20 | 0.588 | 3.87 | 0.002 |
Positive vs. negative | (1.19 - 3.21) | Â | (0.62 - 2.35) | Â | (1.67 - 8.96) | Â |
LVI | 1.34 | 0.250 | 1.47 | 0.261 | 1.56 | 0.268 |
Positive vs. negative | (0.82 - 2.19) | Â | (0.75 - 2.85) | Â | (0.71 - 3.40) | Â |
FOXP3+ iTIL | 0.71 | 0.104 | 0.84 | 0.528 | 0.48 | 0.047 |
≥2 vs. <2 | (0.46 - 1.07) |  | (0.48 - 1.49) |  | (0.23 - 0.98) |  |
Core basal | Â | |||||
Age | 1.01 | 0.957 | 0.77 | 0.301 | 1.53 | 0.245 |
≥50 vs. <50 | (0.68 - 1.50) |  | (0.47 - 1.26) |  | (0.75 - 3.12) |  |
Grade | 1.30 | 0.417 | 1.55 | 0.257 | 1.91 | 0.387 |
3 vs. (1 and 2) | (0.69 - 2.44) | Â | (0.73 - 3.28) | Â | (0.44 - 8.22) | Â |
Tumor size | 1.62 | 0.020 | 2.81 | <0.001 | 0.77 | 0.470 |
>2 cm vs. ≤2 cm | (1.08 - 2.43) |  | (1.67 - 4.72) |  | (0.38 - 1.57) |  |
Nodal status | 2.37 | <0.001 | 2.95 | <0.001 | 1.64 | 0.212 |
Positive vs. negative | (1.53 - 3.66) | Â | (1.68 - 5.17) | Â | (0.75 - 3.56) | Â |
LVI | 1.37 | 0.159 | 0.86 | 0.604 | 3.60 | 0.003 |
Positive vs. negative | (0.88 - 2.13) | Â | (0.49 - 1.51) | Â | (1.56 - 8.29) | Â |
FOXP3+ iTIL | 0.53 | 0.002 | 0.66 | 0.130 | 0.93 | 0.845 |
≥2 vs. <2 | (0.36 - 0.79) |  | (0.39 - 1.13) |  | (0.43 - 2.00) |  |